The Pennant Group, Inc.

PNTG Healthcare Medical Care Facilities

The Pennant Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $947.7 million, up 36.3% from fiscal 2024.

Revenue
+32.0%
EPS
+55.6%
Free cash flow
−3.19%
Total debt
+662.8%

Quarter to September 2026, against a year earlier

36.58 3.42 −8.55%
Market cap
$1.4B
P/E
37.3×
Fwd P/E
36.7×
Dividend yield
—
F-score
5/9
Altman Z
2.29
Beneish M
−2.52
Dividend safety
n/a

An Income Statement, also known as a Profit and Loss Statement, summarizes a company's revenues, expenses, and profits over a specific period. It highlights how revenue is transformed into net income, showcasing operational efficiency. Key components include total revenue, cost of goods sold (COGS), gross profit, operating expenses, and net profit. Businesses use the Income Statement to assess financial performance, make strategic decisions, and ensure profitability. Investors and stakeholders analyze it to gauge the company’s financial health and future growth potential.

Sep '26 From the 10-Q filed 4 Nov Jun '26 Mar '26 Dec '25 Older periods
Revenue
302.25 297.98 285.36 289.32

+8 more quarters

Revenue Growth
31.96% 35.76% 35.99% 53.17%
Gross Profit
40.32 41.92 39.60 39.27
Operating Income
16.51 17.19 17.30 17.47
EBT
14.19 14.83 14.09 14.27
Income after Tax
11.08 10.90 10.29 10.38
Net Income Common
9.64 9.08 8.52 8.64
EPS (Diluted)
0.26 0.25 0.24 0.24
Shares (Diluted, Weighted)
36.38 35.96 35.76 35.32
Gross Margin
13.34% 14.07% 13.88% 13.57%
EBIT Margin
5.46% 5.77% 6.06% 6.04%
Net Profit Margin
3.19% 3.05% 2.99% 2.99%
EBITDA
20.50 20.59 20.22 20.07
EBIT
16.51 17.19 17.30 17.47

Show all line items

In millions of $ except per-share values · columns are period end dates · fundamentals updated 4 Nov 2026